Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 7;12(10):2270.
doi: 10.3390/biomedicines12102270.

Genetic and Neurodevelopmental Markers in Schizophrenia-Spectrum Disorders: Analysis of the Combined Role of the CNR1 Gene and Dermatoglyphics

Affiliations

Genetic and Neurodevelopmental Markers in Schizophrenia-Spectrum Disorders: Analysis of the Combined Role of the CNR1 Gene and Dermatoglyphics

Maria Guardiola-Ripoll et al. Biomedicines. .

Abstract

Background: Dermatoglyphic pattern deviances have been associated with schizophrenia-spectrum disorders (SSD) and are considered neurodevelopment vulnerability markers based on the shared ectodermal origin of the epidermis and the central nervous system. The endocannabinoid system participates in epidermal differentiation, is sensitive to prenatal insults and is associated with SSD. Objective: We aimed to investigate whether the Cannabinoid Receptor 1 gene (CNR1) modulates the dermatoglyphics-SSD association. Methods: In a sample of 112 controls and 97 patients with SSD, three dermatoglyphic markers were assessed: the total palmar a-b ridge count (TABRC), the a-b ridge count fluctuating asymmetry (ABRC-FA), and the pattern intensity index (PII). Two CNR1 polymorphisms were genotyped: rs2023239-T/C and rs806379-A/T. We tested: (i) the CNR1 association with SSD and dermatoglyphic variability within groups; and (ii) the CNR1 × dermatoglyphic measures interaction on SSD susceptibility. Results: Both polymorphisms were associated with SSD. The polymorphism rs2023239 modulated the relationship between PII and SSD: a high PII score was associated with a lower SSD risk within C-allele carriers and a higher SSD risk within TT-homozygotes. This result indicates an inverse relationship between the PII and the SSD predicted probability conditional to the rs2023239 genotype. Conclusions: These novel findings suggest the endocannabinoid system's role in the development and variability of dermatoglyphic patterns. The identified interaction encourages combining genetic and dermatoglyphics to assess neurodevelopmental alterations predisposing to SSD in future studies.

Keywords: CNR1; dermatoglyphics; endocannabinoid system; neurodevelopmental biomarkers; schizophrenia-spectrum disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
(A) Different fingertip patterns (left to right): arch, loop and whorl with the triradius marked with green circles. (B) Handprints where the triradii a and b are indicated. The total a-b ridge count (TABRC) corresponds to the sum of the number of ridges between both triradii from the right and left hands. Figures adapted from [12,23].
Figure 2
Figure 2
Interaction graph showing the interplay between the CNR1-rs2023239 genotype and the pattern intensity index (PII) on the risk for schizophrenia-spectrum disorders (SSD). A lower predicted probability indicates a lower risk towards SSD. Values show the inverse relationship between PII and predicted probability for SSD depending on the rs2023239 genotype.

References

    1. Kahn R.S., Sommer I.E. The Neurobiology and Treatment of First-Episode Schizophrenia. Mol. Psychiatry. 2015;20:84–97. doi: 10.1038/mp.2014.66. - DOI - PMC - PubMed
    1. Birnbaum R., Weinberger D.R. Genetic Insights into the Neurodevelopmental Origins of Schizophrenia. Nat. Rev. Neurosci. 2017;18:727–740. doi: 10.1038/nrn.2017.125. - DOI - PubMed
    1. Compton M.T., Walker E.F. Physical Manifestations of Neurodevelopmental Disruption: Are Minor Physical Anomalies Part of the Syndrome of Schizophrenia? Schizophr. Bull. 2009;35:425. doi: 10.1093/schbul/sbn151. - DOI - PMC - PubMed
    1. Owen M.J., O’Donovan M.C., Thapar A., Craddock N. Neurodevelopmental Hypothesis of Schizophrenia. Br. J. Psychiatry. 2011;198:173–175. doi: 10.1192/bjp.bp.110.084384. - DOI - PMC - PubMed
    1. Tsapakis E.M., Mitkani C.A., Fountoulakis K.N. Neurological Soft Signs and Schizophrenia. CNS Spectr. 2023;28:657–661. doi: 10.1017/S1092852923001189. - DOI - PubMed

LinkOut - more resources